Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Portfolio manager, PN Vijay is of the view that fundamentally Orchid Chemical is not bad stock.
S Kumars Nationwide may test Rs 54, says SP Tulsian, sptulsian.com.
SP Tulsian of sptulsian.com feels investors can make entry in Orchid Chemical.
In Orchid Chemicals if we see a closing above Rs 205 on the weekly basis then we can expect good rally towards Rs 225, says Amit Harchekar, Sr Technical Analyst-India Pvt Clients, IIFL.
SP Tulsian, sptulsian.com says Orchid Chemical’s management has failed to meet its guidance given in FY12.
Shrikant Chouhan of Kotak Securities advises to exit Orchid Chemicals.
See more correction in Orchid Chemicals, says Anu Jain, Vice President, IIFL Private Wealth Management.
Hardik Jain of ISJ Securities advised to hold Orchid Chemicals.
Punit Kinra of Bonanza Portfolio advised selling Orchid Chemicals.
Rajesh Satpute of Mangal Keshav Securities advised selling Orchid Chemicals.
Orchid Chemicals can touch Rs 350 in the next 12 months, says Portfolio Manager, PN Vijay.
Orchid Chemicals may test Rs 200, says Rakesh Gandhi, Senior Tech Analyst, LKP.
VK Sharma of HDFC Securities feels that, from derivatives perspective one would be better placed to look at Orchid Chemical in the news settlement.
Buy S Kumars, Orchid on dips, says Mehraboon Irani, Principal and Head- Pvt Client Group Business, Nirmal Bang Securities.
Kunal Saraogi of Equityrush is of the view that one should sell Orchid Chemicals.
Manoj Murlidhar, AVP-Derivaties, IIFL PReMIA view on S Kumars and Orchid.
Orchid Chemicals and Pharmaceuticals can move to Rs 300, says SP Tulsian, sptulsian.com.
Exit Orchid Chemicals on rally, says Amit Harchekar, IIFL.
Remain Invested in Orchid Chemicals, says SP Tulsian, sptulsian.com.
PN Vijay, Portfolio Manager, www.askpnvijay.com feels that Orchid Chemical should be one of the really good stocks in the midcap pharma space.